drugs_in_development#Net_present_value_in_billion_U.S._dollars
Ide-Cel_(acquired)#6.2
Risdiplam_(in-licensed)#5.3
Valoctocogene_Roxaparvovec__(in-licensed)#5.1
Efgartigimod_(organic)#4.3
Liso-Cel__(acquired)#4.2
Selpercatinib_(acquired)#4.1
Belantamab_Mafodotin__(organic)#3.8
Ripretinib__(organic)#3.1
Tafasitamab_(in-licensed)#2.8
Lenabasum_(in-licensed)#2.7
